249 related articles for article (PubMed ID: 18548136)
1. Acute and long-term antiplatelet therapy.
Papathanasiou AI; Goudevenos JA; Mikhailidis DP; Tselepis AD
Drugs Today (Barc); 2008 May; 44(5):331-52. PubMed ID: 18548136
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy in acute coronary syndromes.
Aragam KG; Bhatt DL
J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):24-42. PubMed ID: 20924098
[TBL] [Abstract][Full Text] [Related]
3. Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
Topol EJ; Easton JD; Amarenco P; Califf R; Harrington R; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Willerson JT; Chan R; Samuels R; Ilson B; Granett J
Am Heart J; 2000 Jun; 139(6):927-33. PubMed ID: 10827369
[TBL] [Abstract][Full Text] [Related]
4. Unresolved issues associated with early initiation of antiplatelet therapy in acute coronary syndromes.
Alagona P
J Invasive Cardiol; 2010 Jan; 22(1):40-4. PubMed ID: 20048399
[TBL] [Abstract][Full Text] [Related]
5. The role of platelets in peripheral arterial disease: therapeutic implications.
Matsagas MI; Geroulakos G; Mikhailidis DP
Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
[TBL] [Abstract][Full Text] [Related]
6. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
7. Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care.
Hankey GJ
Cerebrovasc Dis; 2004; 17 Suppl 3():11-6. PubMed ID: 14730253
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes.
Jennings LK; Saucedo JF
Curr Opin Cardiol; 2008 Jul; 23(4):302-8. PubMed ID: 18520712
[TBL] [Abstract][Full Text] [Related]
9. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet agents.
Varon D; Spectre G
Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
[TBL] [Abstract][Full Text] [Related]
12. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.
Vavalle JP; Rao SV
Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials.
Roule V; Agueznai M; Sabatier R; Blanchart K; LemaƮtre A; Ardouin P; Collet JP; Milliez P; Montalescot G; Beygui F
Platelets; 2017 Mar; 28(2):174-181. PubMed ID: 27657930
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents in stroke prevention. combination therapy: present and future.
Weksler BB
Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
[TBL] [Abstract][Full Text] [Related]
15. Oral platelet glycoprotein IIb/IIIa inhibition.
Newby LK; McGuire DK
Curr Cardiol Rep; 2000 Sep; 2(5):372-7. PubMed ID: 10980903
[TBL] [Abstract][Full Text] [Related]
16. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents.
Schafer AI
Tex Heart Inst J; 1997; 24(2):90-6. PubMed ID: 9205981
[TBL] [Abstract][Full Text] [Related]
18. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
Umman B
Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
[TBL] [Abstract][Full Text] [Related]
19. GP IIb/IIIa blockade during peripheral artery interventions.
Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
[TBL] [Abstract][Full Text] [Related]
20. [Update on the treatment with platelet antiaggregation agents].
Rodrigues HL
Rev Port Cardiol; 2001 Jan; 20(1):79-95. PubMed ID: 11291339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]